as the first rapid-acting insulin biosimilar to Novolog (insulin aspart). This new treatment option, aimed at enhancing glycemic control for individuals with diabetes mellitus, offers a critical ...

NovoLog is also available in pen injector ... having a biosimilar option for their rapid-acting insulin injection can truly make a difference, as biosimilar products have the potential to increase ...

The fastest (and preferred) way to quickly lower blood sugar is to take rapid-acting insulin such as Humalog, Novolog, or Apidra. If you have type 1 diabetes and use an insulin pump, you may be ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...

2.4%). Hypoglycemia occurred more often with 70/30 insulin. This study was funded by the maker of Novolog. These two studies aren't entirely congruent: The first one pitted a glargine-plus-oral ...

Basal insulin called insulin degludec - this has a long blood sugar lowering effect. Rapid acting insulin called insulin aspart - this lowers your blood sugar soon after you inject it. Ryzodeg ...